KALV

Kalvista Pharm

• TipRanks·05/16 06:00

  Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks

• TipRanks·05/15 11:41

  Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), PTC Therapeutics (PTCT) and Veru (VERU)

• Reuters·05/08 11:18

  KALVISTA PHARMACEUTICALS INC <KALV.O>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $27 FROM $42

• Reuters·05/08 07:12

  U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson

• TipRanks·05/07 20:46

  KalVista downgraded to Hold from Buy at Stifel

• Seeking Alpha·05/05 14:05

  Most and least shorted small-to-mid-cap stocks

• Seeking Alpha·05/04 13:50

  Most and least shorted healthcare stocks with up to $2B market cap in May

• Seeking Alpha·05/03 15:15

  Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more

• Benzinga·05/01 18:35

  Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy

• Dow Jones·05/01 10:52

  KalVista Pharmaceuticals Cut to Neutral From Buy by HC Wainwright & Co.

• Dow Jones·05/01 10:52

  KalVista Pharmaceuticals Price Target Cut to $27.00/Share From $37.00 by HC Wainwright & Co.

• Benzinga·05/01 10:42

  HC Wainwright & Co. Downgrades KalVista Pharmaceuticals to Neutral, Lowers Price Target to $27

• Reuters·05/01 10:33

  KALVISTA PHARMACEUTICALS INC <KALV.O>: H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY

• TipRanks·05/01 10:30

  Analysts Offer Insights on Healthcare Companies: HOYA (OtherHOCPF), Sagimet Biosciences, Inc. Class A (SGMT) and KalVista Pharmaceuticals (KALV)

• TipRanks·05/01 10:15

  KalVista downgraded to Neutral from Buy at H.C. Wainwright